Literature DB >> 26957642

Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Summary.

Lyndsay N Harris1, Nofisat Ismaila1, Lisa M McShane1, Daniel F Hayes1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26957642     DOI： 10.1200/JOP.2016.010868

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN： 1554-7477            Impact factor:   3.840


× No keyword cloud information.
  13 in total

1.  Current Biomarkers for Precision Medicine in Breast Cancer.

Authors:  Soo Kyung Ahn; So-Youn Jung
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Extended Endocrine Therapy: Is 5 Years Enough?

Authors:  Manali A Bhave; N Lynn Henry
Journal:  Curr Oncol Rep       Date:  2017-03       Impact factor: 5.075

3.  Feasibility of lung cancer RNA acquisition from a single transbronchial or transthoracic needle pass (FASTT trial).

Authors:  Travis Dotson; Christina Bellinger; Jing Su; Kris Hansen; Graham E Parks; James O Cappellari; Lou Craddock; Hollins Clark; Clifford Howard; W Jeffrey Petty; Bharat Prakash; Kounosuke Watabe; Michael Chan; Jonathan Hovda; Lance D Miller; Jimmy Ruiz
Journal:  Lung Cancer       Date:  2018-11-20       Impact factor: 5.705

Review 4.  Statistical controversies in clinical research: prognostic gene signatures are not (yet) useful in clinical practice.

Authors:  S Michiels; N Ternès; F Rotolo
Journal:  Ann Oncol       Date:  2016-09-15       Impact factor: 32.976

5.  Highlights from the 15th St Gallen International Breast Cancer Conference 15-18 March, 2017, Vienna: tailored treatments for patients with early breast cancer.

Authors:  Consuelo Morigi
Journal:  Ecancermedicalscience       Date:  2017-04-07

6.  Gene expression assay and Watson for Oncology for optimization of treatment in ER-positive, HER2-negative breast cancer.

Authors:  Yun Yeong Kim; Se Jeong Oh; Yong Soon Chun; Woon Kee Lee; Heung Kyu Park
Journal:  PLoS One       Date:  2018-07-06       Impact factor: 3.240

7.  Gene Expression Analyses in Breast Cancer: Sample Matters.

Authors:  Benjamin Haibe-Kains; David W Cescon
Journal:  JNCI Cancer Spectr       Date:  2018-05-22

Review 8.  Optimal duration of adjuvant endocrine therapy: how to apply the newest data.

Authors:  Kerstin Wimmer; Stephanie Strobl; Michael Bolliger; Yelena Devyatko; Belgin Korkmaz; Ruth Exner; Florian Fitzal; Michael Gnant
Journal:  Ther Adv Med Oncol       Date:  2017-10-27       Impact factor: 8.168

9.  Ki67 Is an Independent Predictor of Recurrence in the Largest Randomized Trial of 3 Radiation Fractionation Schedules in Localized Prostate Cancer.

Authors:  Anna C Wilkins; Barry Gusterson; Zsolt Szijgyarto; Joanne Haviland; Clare Griffin; Christine Stuttle; Frances Daley; Catherine M Corbishley; David P Dearnaley; Emma Hall; Navita Somaiah
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-02-03       Impact factor: 7.038

10.  DEAD-box RNA Helicase 39 Promotes Invasiveness and Chemoresistance of ER-positive Breast Cancer.

Authors:  Xiudi Wang; Peipei Li; Chenying Wang; Dagui Zhang; Linghui Zeng; Xiyong Liu; Jiajin Lin
Journal:  J Cancer       Date:  2020-01-20       Impact factor: 4.207
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.